Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
8,936,177
-
Share change
-
+30,631
-
Total reported value
-
$153,339,825
-
Price per share
-
$17.16
-
Number of holders
-
43
-
Value change
-
+$3,278,563
-
Number of buys
-
22
-
Number of sells
-
23
Institutional Holders of CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) as of Q4 2015
As of 31 Dec 2015,
CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,936,177 shares.
The largest 10 holders included
FMR LLC, FRAZIER MANAGEMENT LLC, RA CAPITAL MANAGEMENT, LLC, Aisling Capital LLC, PERCEPTIVE ADVISORS LLC, GOLDMAN SACHS GROUP INC, BB BIOTECH AG, EVENTIDE ASSET MANAGEMENT, LLC, Rock Springs Capital Management LP, and Broadfin Capital, LLC.
This page lists
43
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.